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Abstract
Although earlier trauma exposure is known to predict post-traumatic stress disorder (PTSD) after 
subsequent traumas, it is unclear if this association is limited to cases where the earlier trauma led 
to PTSD. Resolution of this uncertainty has important implications for research on pre-trauma 
vulnerability to PTSD. We examined this issue in the WHO World Mental Health (WMH) Surveys 
with 34,676 respondents who reported lifetime trauma exposure. One lifetime trauma was selected 
randomly for each respondent. DSM-IV PTSD due to that trauma was assessed. We reported in a 
previous paper that four earlier traumas involving interpersonal violence significantly predicted 
PTSD after subsequent random traumas (OR=1.3–2.5). We also assessed 14 lifetime DSM-IV 
mood, anxiety, disruptive behavior, and substance disorders prior to random traumas. We show in 
the current report that only prior anxiety disorders significantly predicted PTSD in a multivariate 
model (OR=1.5–4.3) and that these disorders interacted significantly with three of the earlier 
traumas (witnessing atrocities, physical violence victimization, rape). History of witnessing 
atrocities significantly predicted PTSD after subsequent random traumas only among respondents 
with prior PTSD (OR=5.6). Histories of physical violence victimization (OR=1.5) and rape after 
age 17 (OR=17.6) significantly predicted only among respondents with no history of prior anxiety 
disorders. Although only preliminary due to reliance on retrospective reports, these results suggest 
that history of anxiety disorders and history of a limited number of earlier traumas might usefully 
be targeted in future prospective studies as distinct foci of research on individual differences in 
vulnerability to PTSD after subsequent traumas.
INTRODUCTION
Only a minority of people ever develops post-traumatic stress disorder (PTSD)1 despite 
traumas occurring to the vast majority of the population.2 This suggests that individual 
differences exist in vulnerability to traumas.3–5 Increased understanding of these differences 
could help inform intervention development.6 In addition, measurement of these differences 
shortly after trauma exposure could help target high-risk individuals for preventive 
interventions.7 Epidemiological research shows that earlier trauma exposure and history of 
psychopathology are the two strongest pre-trauma predictors PTSD after subsequent 
traumas.8 Earlier trauma exposure is particularly interesting because, unlike 
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psychopathology, earlier traumas are external to the individual and presumably predict 
future PTSD because (i) exposure to these traumas is influenced by stable vulnerability 
factors and/or (ii) exposure to these traumas causes biological and/or psychological 
vulnerabilities to subsequent PTSD. Childhood adversities (CAs) have been of special 
interest, as they occur early in life and are strongly associated with increased risk of 
psychopathology throughout the life course.9, 10 However, it is difficult to tease apart the 
effects of pre-existing vulnerability factors and intervening biological and psychological 
processes in studying CAs. There are two reasons for this. First, CAs are strongly associated 
with parental psychopathology and, by extension, genetic risk.11 Second, a high proportion 
of the most severe CAs are associated with child- and adolescent-onset mental disorders and 
long-term neurobiological and psychological changes due to those disorders that are 
associated with risk of a range of later disorders.12
The effects of earlier traumas not involving CAs on PTSD after subsequent traumas might 
be easier to study than CAs to the extent that exposure to earlier traumas is more 
independent than CAs of prior psychopathology and genetic risk. A potential limitation, 
though, is that some,13, 14 although not all,15 epidemiological studies suggest that 
associations of earlier traumas with PTSD after subsequent traumas are limited to people 
who developed PTSD due to the earlier traumas. If true, this specification would reintroduce 
the same complication as in research on CAs. Resolution of this uncertainty could have 
important implications for future research on the environmental determinants of individual 
differences in vulnerability to PTSD.16
We attempt to take a first step in resolving this uncertainty here by analyzing data from a 
unique sample of 34,676 respondents who reported lifetime exposure to one or more 
traumas in the WHO World Mental Health (WMH) Surveys.7 In a previous report,17 we 
showed that four trauma groups/types, all involving interpersonal violence, had significantly 
elevated relative-odds of predicting DSM-IV PTSD after subsequent traumas. We also 
showed in that report that these associations did not vary depending on type of subsequent 
trauma. However, in that earlier report we did not explore the possibility that the 
associations of these earlier traumas with later PTSD might depend on history of PTSD or 
other common DSM-IV disorders related to the earlier traumas. We do this in the current 
report.
METHODS AND MATERIALS
Sample
Data come from 22 community epidemiological surveys in the larger WMH series that 
assessed lifetime PTSD after randomly-selected traumas. By randomly selected we mean 
that one occurrence of one lifetime trauma reported by each respondent was selected at 
random for retrospective assessment of PTSD. We adjusted for individual differences in 
number of lifetime trauma exposures by weighting random trauma data a the individual level 
by the respondent’s number of lifetime traumas, generating a weighted sample 
representative of all trauma occurrences in the population rather than of all individuals in the 
population. The joint associations of earlier lifetime traumas and history of psychopathology 
with PTSD after the subsequent random trauma are the focus of the current report
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Three of the 22 surveys were in low/lower-middle income countries (Colombia, Peru, 
Ukraine), seven in upper-middle income countries (Brazil, Bulgaria, Colombia 
[administered after the previously-mentioned Colombian survey, when the World Bank 
country income rating had increased], Lebanon, Mexico, Romania, South Africa), and 12 in 
high income countries (Belgium, France, Germany, Israel, Italy, Japan, Netherlands, New 
Zealand, Northern Ireland, Spain [separate national and regional surveys], United States) 18 
Each survey was based on a multi-stage clustered area probability sample of adult household 
residents. Three surveys were limited to all urbanized areas in their countries (Colombia, 
Mexico, Peru), four others to specific Metropolitan areas (Sao Paulo Brazil; Medellin 
Colombia, Murcia Spain, six cities in Japan), and the remaining 15 represented the full 
household populations in their countries.
Interviews were administered face-to-face in respondent homes by trained lay interviewers 
after obtaining informed consent using procedures approved by local Institutional Review 
Boards.19 The weighted (by sample size) mean response rate was of 71.3% across surveys 
(from 45.9% in France to 97.2% in Medellin). The interview was in two parts. Part I, 
administered to all n=101,454 respondents, assessed core DSM-IV mental disorders. Part II, 
administered to Part I respondents with core disorders and a probability subsample of other 
respondents (n=54,600), assessed additional disorders and correlates. Traumas and PTSD 
were assessed in Part II. The analysis sample considered here includes the 34,676 Part II 
respondents who reported lifetime trauma exposure. Each Part II respondent was weighted 
by the inverse of his/her selection probability into Part II, within- household variation in 
selection probabilities (due to one respondent being selected per household regardless of 
household size), between-household variation in selection probabilities (due to under-
sampling hard-to-reach respondents in the last recruitment phase), and to match the sample 
with the population on Census geographic/socio-demographic variables. Details about these 
weights are presented elsewhere.20
Measures
Traumas—Twenty-nine trauma types were assessed. These included traumas involving 
exposure to organized violence (e.g., civilian in war zone, relief worker in war zone, 
refugee), participation in organized violence (e.g., combat experience, witnessed atrocities), 
physical violence victimization (e.g., beaten by caregiver as child; beaten by someone else), 
sexual violence victimization (e.g., raped, sexually assaulted, beaten by romantic partner), 
accidents/injuries (e.g., natural disaster, automobile accident), and unexpected death of loved 
one).2 Age of first exposure was recorded for each trauma type reported.
DSM-IV disorders—Fourteen lifetime DSM-IV disorders were assessed with the fully-
structured Composite International Diagnostic Interview (CIDI):21 two mood disorders 
(major depressive disorder/dysthymic disorder and broadly-defined bipolar disorder [bipolar 
I and II and sub-threshold bipolar disorder, defined using criteria described elsewhere]);22 
six anxiety disorders (generalized anxiety disorder, panic disorder and/or agoraphobia, 
posttraumatic stress disorder, separation anxiety disorder, social phobia, specific phobia); 
four disruptive behavior disorders (attention-deficit/hyperactivity disorder, conduct disorder, 
intermittent explosive disorder, oppositional-defiant disorder); and two substance disorders 
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(alcohol and drug abuse with or without dependence). PTSD was unique in being assessed 
twice: once for the random trauma and a second time for the lifetime trauma nominated by 
the respondent as having caused the most distress-impairment. Age-of-onset of each disorder 
was assessed using probing techniques shown experimentally to improve recall accuracy,23 
allowing us to determine whether respondents had a history of each disorder prior to 
exposure to the random trauma. DSM-IV organic exclusion and diagnostic hierarchy rules 
were not used in making diagnoses. As detailed elsewhere,24 generally good concordance 
was found between diagnoses based on the CIDI and blinded clinical diagnoses based on 
SCID reappraisal interviews.25
Analysis Methods
Random trauma reports were weighted by the inverse of their within-person probability of 
selection multiplied by the Part II weight to generate a sample representative of all traumas 
experienced by all respondents. This composite weight was standardized within surveys to 
equal the number of respondents reporting lifetime traumas and then pooled across surveys. 
Logistic regression was used to estimate associations of earlier traumas and random trauma 
types with subsequent PTSD after random traumas controlling sex, age at random trauma 
exposure, and survey. This model, the results of which were reported previously,17 was then 
expanded in the analyses reported here to evaluate whether temporally prior (to the random 
trauma) lifetime DSM-IV/CIDI disorders influenced associations of earlier traumas with 
PTSD after subsequent random traumas. We considered both additive models where prior 
lifetime disorders were controls and models that included interactions of earlier traumas 
with lifetime disorders.
Temporal ordering between earlier traumas and lifetime disorders was complex due to many 
respondents having multiples of both. As a result, the main effects of mental disorders as 
predictors were explained without attempting to distinguish between mental disorders as risk 
markers (i.e., temporally primary predictors of both earlier traumas and PTSD after 
subsequent traumas) versus as mediators (i.e., earlier traumas predicted later mental 
disorders, which, in turn, predicted PTSD after subsequent random traumas). However, in 
cases where interactions were found and the association of the earlier trauma with the 
outcome was significant in the presence of mental disorders, we decomposed the association 
to determine if the OR associated with the earlier traumas depended on whether the mental 
disorders occurred before or only after those traumas.
Statistical significance was consistently evaluated using .05-level two-sided design-based 
tests. The Taylor series method26 implemented in the SAS software system27 was used to 
adjust estimates of standard errors for survey design effects. Logistic regression coefficients 
and their standard errors were exponentiated to create odds-ratios (ORs) and 95% 
confidence intervals (CIs). Design-based Wald χ2 tests were used to evaluate significance of 
predictor sets.
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RESULTS
Associations of DSM-IV/CIDI disorders with PTSD after subsequent random traumas
All 14 prior lifetime DSM-IV/CIDI disorders had increased ORs predicting PTSD after 
random traumas in bivariate models. (Table 1, Bivariate Model) The highest OR was for 
prior PTSD (5.7) and the lowest for conduct disorder (1.1). Ten of the 14 bivariate ORs were 
statistically significant. However, in a multivariate model containing all 14 disorders (Table 
1, Model 1.1), only the anxiety disorders remained significant as a set (χ26=112.1, p<.001). 
The ORs for the 6 individual anxiety disorders differed significantly among themselves 
(χ25=26.8, p<.001), with 5 of the 6 ORs significant (the exception was panic/agoraphobia) 
and in the range between 4.3 for PTSD and 1.5 for social phobia.
A global interaction test for number of anxiety disorders was non-significant in an expanded 
model that included separate coefficients for history of each individually significant anxiety 
disorder and a count variable. (Model 1.2) The interaction was also non-significant in a 
revised model that included separate dummy variables for respondents with histories of 
between 2 and all 5 significant anxiety disorders. (Model 1.3) These results demonstrated 
clearly that the joint associations of prior anxiety disorders with PTSD after subsequent 
traumas were additive on a logistic scale (Model 1.4).
Interactions between earlier traumas and history of anxiety disorders
As noted in the introduction, we showed in a previous report that four earlier trauma groups/
types, all involving interpersonal violence, predicted DSM-IV PTSD after subsequent 
random traumas. The first of these earlier traumas was participation in organized violence 
(OR=1.3; a composite of five trauma types with a combined prevalence of 26.1%, including 
combat experience; purposefully injuring, torturing, or killing someone; accidentally 
injuring or killing someone; witnessing serious injury/death or discovering a dead body; and 
witnessing atrocities). The second was physical violence victimization (OR=1.4; a 
composite of three trauma types with a combined prevalence of 26.4% that included 
witnessing physical violence at home as a child; physical abuse by a caregiver as a child; 
beaten up by someone else). The third and fourth were rape (OR=2.5; 4.5% prevalence) and 
other sexual assault (OR=1.6; 7.6% prevalence).17
Based on the results in Table 1, we investigated how much the gross associations of earlier 
traumas with PTSD after subsequent random traumas (Table 2, Model 2.1) were due to the 
anxiety disorders in Model 1.4. We began with an additive model. (Model 2.2) The ORs of 
all four earlier trauma groups/types became non-significant in that model (OR=1.1–1.6) and 
those of all five anxiety disorders remained significant with ORs in the range between 4.3 
for PTSD and 1.5 for social phobia. We then tested the significance of interactions between 
earlier traumas and a three-category anxiety disorder profile score: (i) prior PTSD regardless 
of presence/absence of any other anxiety disorders (2.8% of the sample); (ii) no prior PTSD, 
but one or more other significant anxiety disorders (16.1% of the sample), and (iii) none of 
the prior anxiety disorders (81.1% of the sample). These interactions were significant overall 
(χ28=32.5, p<.001), with significant component interactions for participation in organized 
violence (χ22=10.1, p=.006) and physical violence victimization (χ22=10.5, p=.005), a near-
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significant interaction for rape (χ22=5.8, p=.056), and a non-significant interaction for other 
sexual assault (χ22=0.2, p=.89).
Subgroup coding of the significant and near-significant interactions showed that the OR of 
participation in organized violence was significant only among respondents with prior PTSD 
(OR=2.0) and that the ORs of physical violence victimization and rape were significant only 
among respondents with no prior anxiety disorders (OR=1.5 for physical violence 
victimization and 3.4 for rape; Model 2.3). The OR of other sexual assault, in comparison, 
was non-significant in all three subgroups. Further analyses described next then investigated 
the significant within-subgroup associations that accounted for the interactions.
Participation in organized violence—As noted above, participation in organized 
violence was a composite of five trauma types. Disaggregation showed that only one of these 
five, witnessing atrocities, accounted for the significant subgroup OR of the composite 
among respondents with a history of prior PTSD. The OR for witnessing atrocities (with or 
without any of the other four traumas in the composite) predicting PTSD after subsequent 
random traumas was OR=5.6 (95% CI=1.6–20.3), whereas the OR for one or more of the 
other four traumas in the composite was OR=0.8 (95% CI=0.4–1.5). We also investigated 
whether the significant OR for witnessing atrocities among people with a history of prior 
PTSD varied significantly by whether age at first witnessing atrocities was before or after 
age-of-onset of PTSD. It did not (χ21=0.0, p=.95), although the number of respondents with 
a history of both witnessing atrocities and having PTSD prior to the random trauma was 
small (n=40).
Physical violence victimization—We also noted above that physical violence 
victimization was a composite of three trauma types. Disaggregation failed to find evidence 
that these three differed in importance in accounting for the significant subgroup OR of the 
composite among respondents with no prior anxiety disorders (χ22=2.9, p=.24).
Rape—Although the WMH surveys collected information about circumstances surrounding 
the rapes selected as random traumas,28 the only information collected about other rapes was 
age at first exposure. Disaggregation of the subgroup OR of rape among respondents with no 
history of anxiety disorder was limited to adult-onset (ages 18+) rapes (OR=17.6, 95% 
CI=6.6–47.1). The OR associated with childhood-onset (ages 4–17) rapes was not 
significant (OR=1.5, 95% CI=0.8–2.9). It is noteworthy, though, that this disaggregation is 
based on an earlier interaction that was only near-significant.
Population distributions
It is instructive to project the above results to the population by dividing the total WMH 
sample (i.e., including respondents with no history of earlier trauma exposure) into the three 
subgroups of: (i) individuals with a history of any anxiety disorder that predicted PTSD; (ii) 
individuals without any such disorder but with exposure to the earlier traumas found to 
predict PTSD after subsequent traumas (i.e., witnessing atrocities and adult rape 
victimization); and (iii) other respondents. (Table 3) These three subgroups made up 13.8%, 
12.3%, and 73.9% respectively, of the total sample. When we classified each WMH 
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respondent using this scheme as of 5 years before interview, we found a significantly higher 
rate of new trauma exposure among respondents in the first (71.9/100 respondents) and 
second (72.7/100) subgroups than the third (27.5/100) subgroups (χ22=1,359.5, p<.001).
We also saw from the trauma-level sample that conditional PTSD prevalence after random 
traumas was much higher among respondents in the first (10.6%) than second (3.5%) or 
third (2.2%) subgroups (χ22=182.0, p<.001). Based on these distributions, we estimated that 
approximately 57.9% of PTSD cases occur among people in the first subgroup, 17.4% in the 
second, and 24.7% in the third subgroup. We also estimated that 7.6 new cases of PTSD 
would be found per 100 respondents by following respondents in the first subgroup over a 
period of 5 years compared to 2.6/100 in the second and 0.6/100 in the third subgroup. The 
roughly 2-fold higher number of PTSD cases in the first than second subgroup is due 
entirely to higher PTSD risk after trauma exposure. The nearly 4-fold higher number of 
cases in the second than third subgroup, in comparison, is due to a combination of a 
substantially higher rate of trauma exposure and a significantly higher PTSD risk after 
trauma exposure.
DISCUSSION
The main advantage of the WMH design over previous studies in examining the associations 
of earlier traumas with PTSD after subsequent traumas is its large size, which allows more 
fine-grained assessments of intervening and interactive associations than previous studies. 
The WMH surveys were limited, though, by being cross-sectional, raising the possibility of 
biased recall about history of earlier traumas. Other limitations were that comorbid physical 
disorders and treatments were not taken into consideration and diagnoses of mental 
disorders were made with fully-structured interviews rather than semi-structured clinical 
interviews.
Within the context of these limitations, our finding that numerous mental disorders had 
significant gross associations with PTSD after subsequent traumas is broadly consistent with 
previous research.8, 29, 30 Although no previous study examined the full range of mental 
disorders considered here, prospective studies of pre-trauma biological and psychological 
vulnerabilities are indirectly consistent with our finding that anxiety disorders are the most 
important class of prior disorders in predicting subsequent PTSD.3, 30, 31 More direct 
evaluation of this variation is needed in future prospective studies, though, possibly in 
conjunction with an investigation of the unanticipated finding in Table 3 that prior anxiety 
disorders were associated with increased risk of subsequent trauma exposure and the 
possibility that this pattern is due to stress-generating effects of anxiety disorders.
Our finding that history of exposure to traumas involving interpersonal violence is 
associated with significantly elevated risk of PTSD after subsequent traumas is also 
consistent with previous research.8, 29 However, previous research was more equivocal on 
whether earlier traumas are important only when they result in PTSD. Breslau et al.14 first 
documented this specification in a prospective epidemiological sample of young adults, 
documenting that the significant association of a dichotomous measure of baseline trauma 
history with increased PTSD risk after subsequent traumas was limited to respondents with a 
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baseline history of PTSD. Cougle et al.,15 in a larger prospective study of adolescent 
assaultive violence (physical or sexual) subsequently showed that respondents with a 
baseline history assaultive violence victimization without PTSD were significantly more 
likely than others to develop PTSD after a subsequent trauma. Breslau and Peterson13 then 
reported a failure to replicate this specification in a cross-sectional community 
epidemiological survey that, like the WMH surveys, assessed PTSD separately for each 
respondent’s most upsetting lifetime trauma and a randomly selected lifetime trauma. 
However, trauma history was defined in the Breslau-Peterson sample only in terms of most 
upsetting lifetime trauma, resulting in some respondents classified as having a history of 
only nonviolent trauma exposure actually being exposed to assaultive violence.
It is somewhat surprising given the potential importance of this specification that no 
subsequent studies carried out more definitive investigations. If the association of trauma 
history with PTSD after subsequent traumas is due entirely to the mediating effects of PTSD 
caused by earlier traumas, then trauma history cannot be considered an environmental risk 
factor for future PTSD. On the other hand, if history of at least some trauma types in the 
absence of history of mental disorder reliably predicts PTSD after subsequent traumas, 
individuals with a history of exposure to these earlier traumas could be targeted for intensive 
baseline evaluation and prospective study of premorbid modifiable biological and 
psychological vulnerabilities to PTSD in future prospective studies of trauma victims.
Our results provide the first evidence that at least two earlier traumas -- physical violence 
victimization and, more provisionally (due to the total-sample p value only being near-
significant), adult rape -- are associated with PTSD after subsequent traumas among people 
who did not have anxiety disorders either before or after the earlier traumas. Although only 
provisional because they are based on cross-sectional data, these results raise the possibility 
that investigators designing future prospective studies might profit from over-sampling 
baseline respondents who had these earlier traumas but did not have a history of anxiety 
disorders for purposes of enriching prospective analyses of vulnerability factors for 
subsequent PTSD. Why these individuals might be at elevated risk of subsequent PTSD is 
unclear, but a number of suggestions exist in the literature about developmental, 
psychosocial, and neurobiological factors that could either be risk factors for exposure to or 
consequences of these earlier traumas.3, 6, 30 We showed that a meaningful proportion of the 
population falls into this subgroup, making over-sampling feasible to enrich investigation of 
vulnerabilities that are independent of prior anxiety disorders. Replicating results regarding 
predictive associations of biological and psychological vulnerabilities in such an enriched 
over-sample could help evaluate the independence of presumed causal factors from earlier 
mental disorders in a way that substantially improves on more standard approaches of using 
multivariate methods to control for such potential confounders.31
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